CRL
Charles River Laboratories International Inc.
$155.39
-$1.60(-1.02%)
60
Overall
--
Value
66
Tech
55
Quality
Market Cap
$7.46B
Volume
1.28M
52W Range
$91.86 - $230.02
Target Price
$174.00
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $1.4B | $1.7B | $1.9B | $2.3B | $2.6B | $2.9B | $3.5B | $4.0B | $4.1B | $4.0B | ||
| Total Revenue | $1.4B | $1.7B | $1.3B | $1.7B | $2.6B | $2.9B | $3.5B | $4.0B | $4.1B | $4.0B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $568.2M | $757.7M | $867.0M | $1.2B | $1.4B | $1.9B | $2.2B | $2.5B | $6.3M | $47.0M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $531.1M | $646.7M | $700.9M | $840.1M | $1.2B | $1.1B | $1.3B | $1.5B | $4.1B | $4.0B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $324.6M | $409.2M | $412.6M | $508.7M | $607.2M | $640.8M | $744.8M | $811.7M | $885.3M | $889.5M | ||
| Selling, General & Administrative | $300.4M | $367.5M | $371.3M | $443.9M | $517.6M | $528.9M | $619.9M | $665.1M | $747.9M | $751.0M | ||
| Selling & Marketing Expenses | $300.4M | $367.5M | $371.3M | $443.9M | -- | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $-23.4M | $-21.8M | $-26.3M | $-30.4M | $517.6M | $528.9M | $619.9M | $665.1M | $747.9M | $751.0M | ||
| Promotion & Advertising | $-1.2M | $-1.4M | $-1.6M | $-1.9M | -- | -- | -- | -- | -- | -- | ||
| Salaries & Wages | $-40.1M | $-43.6M | $-44.0M | $-47.3M | $-9.5M | $-8.1M | $-10.3M | $-11.0M | $-10.9M | $-10.5M | ||
| Depreciation & Amortization | $24.2M | $41.7M | $41.4M | $64.8M | $89.5M | $111.9M | $124.9M | $146.6M | $137.4M | $138.5M | ||
| Depreciation & Amortization | $24.2M | $41.7M | $41.4M | $64.8M | $89.5M | $111.9M | $124.9M | $146.6M | $137.4M | $138.5M | ||
| Amortization | $24.2M | $41.7M | $41.4M | $64.8M | $89.5M | $111.9M | $124.9M | $146.6M | $137.4M | $138.5M | ||
| Other Operating Expenses | $-2.4M | $-2.2M | $-15.7M | $-21.2M | $-3.7M | $-7.0M | $-9.5M | $-134.9M | $-3.1M | $-10.7M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $206.4M | $237.4M | $288.3M | $331.4M | $351.2M | $432.7M | $589.9M | $651.0M | $617.3M | $227.3M | ||
| EBITDA | $307.8M | $377.3M | $457.9M | $507.2M | $563.1M | $768.5M | $820.2M | $986.1M | $3.7B | $3.3B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $15.1M | $27.7M | $29.8M | $63.8M | $60.9M | $86.4M | $73.9M | $59.3M | $1.5M | $1.5M | ||
| Intinc | $1.0M | $1.3M | $690.0K | $812.0K | $1.5M | $834.0K | $652.0K | $780.0K | $5.2M | $8.6M | ||
| Net Non-Operating Interest Income/Expense | $-14.0M | $-26.4M | $-29.1M | $-63.0M | $-59.4M | $-85.6M | $-73.3M | $-58.5M | $5.2M | $8.6M | ||
| Gain on Sale of Securities | $3.8M | $10.3M | $22.9M | $15.9M | -- | -- | -- | -- | -- | -- | ||
| Other Income/Expense | $-3.0M | $-11.9M | $-37.8M | $-13.3M | $-12.3M | $-100.0M | $35.9M | $30.5M | $-95.5M | $16.5M | ||
| Other Special Charges | $3.0M | $11.9M | $37.8M | $13.3M | $12.3M | $100.0M | $-35.9M | $30.5M | $95.5M | $-16.5M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $-63.3M | $-55.3M | $-82.4M | $-140.1M | $-140.5M | $-166.6M | $-228.8M | $-324.7M | $-318.5M | $-233.0M | ||
| Special Income Charges | $63.3M | $57.2M | $82.4M | $140.1M | $140.5M | $166.6M | $260.7M | $327.9M | $318.5M | $-215.0M | ||
| Impairment of Capital Assets | -- | $-1.9M | -- | -- | -- | -- | -- | -- | -- | $215.0M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $210.5M | $250.6M | $326.7M | $345.5M | $365.0M | $533.5M | $554.6M | $682.3M | $3.3B | $2.9B | ||
| Pre-Tax Income | $195.4M | $222.9M | $297.0M | $281.7M | $304.1M | $447.1M | $480.7M | $623.0M | $3.3B | $2.9B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $43.4M | $66.8M | $171.4M | $54.5M | $50.0M | $81.8M | $81.9M | $130.4M | $100.9M | $67.8M | ||
| NET INCOME | ||||||||||||
| Net Income | $152.0M | $156.4M | $125.6M | $228.7M | $252.0M | $364.3M | $391.0M | $486.2M | $474.6M | $22.2M | ||
| Net Income (Continuing Operations) | $152.0M | $156.4M | $125.6M | $228.7M | $252.0M | $364.3M | $391.0M | $492.6M | $3.2B | $2.9B | ||
| Net Income (Discontinued Operations) | $152.0M | $156.4M | $125.6M | $228.7M | $252.0M | $364.3M | $391.0M | $486.2M | $474.6M | $22.2M | ||
| Net Income (Common Stockholders) | $149.3M | $154.8M | $123.4M | $226.4M | $252.0M | $364.3M | $391.0M | $486.2M | $474.6M | $10.3M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $2.9B | ||
| TOTALS | ||||||||||||
| Total Expenses | $892.9M | $1.2B | $1.3B | $1.7B | $2.0B | $2.2B | $2.6B | $3.3B | $891.6M | $936.5M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $46.5M | $47.0M | $47.5M | $47.9M | $48.7M | $49.5M | $50.3M | $50.8M | $51.2M | $51.4M | ||
| Average Shares Outstanding (Diluted) | $47.6M | $48.0M | $48.6M | $49.0M | $49.7M | $50.6M | $51.4M | $51.3M | $51.5M | $51.6M | ||
| Shares Outstanding | $46.7M | $47.4M | $47.4M | $48.2M | $49.0M | $49.8M | $50.5M | $51.0M | $51.3M | $51.1M | ||
| Basic EPS | $3.21 | $3.29 | $2.6 | $4.72 | $5.17 | $7.35 | $7.77 | $9.57 | $9.27 | $0.20 | ||
| Basic EPS (Continuing Operations) | $3.23 | $3.28 | $2.6 | $4.69 | $5.17 | $7.35 | $7.77 | $9.57 | $9.27 | $0.20 | ||
| Diluted EPS | $3.13 | $3.23 | $2.54 | $4.62 | $5.07 | $7.2 | $7.6 | $9.48 | $9.22 | $0.20 | ||
| Diluted EPS (Continuing Operations) | $3.15 | $3.22 | $2.54 | $4.59 | $5.07 | $7.2 | $7.6 | $9.48 | $9.22 | $0.20 | ||
| OTHER METRICS | ||||||||||||
| Accretion On Preferred Stock | -- | -- | -- | -- | -- | -- | -- | $7.5M | $-5.7M | -- | ||
| Basic Discontinuous Operations | $-0.02 | $0.01 | -- | $0.03 | -- | -- | -- | -- | -- | -- | ||
| Diluted Discontinuous Operations | $-0.02 | $0.01 | -- | $0.03 | -- | -- | -- | -- | -- | -- | ||
| Earnings from equity interest | $7.3M | $7.1M | $10.1M | $18.2M | $-11.4M | $-27.6M | $-40.2M | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | $7.3M | $7.1M | $10.1M | $18.2M | $-11.4M | $-27.6M | $-40.2M | -- | -- | -- | ||
| Gain On Sale Of Business | -- | $-788.0K | -- | -- | $20.7M | $100.4M | $25.0M | $123.4M | $-961.0K | $-659.0K | ||
| Gains Loss On Disposal Of Discontinued Operations | $-950.0K | $280.0K | $-137.0K | $1.5M | -- | -- | -- | -- | -- | -- | ||
| Interest Expense Operating | -- | -- | -- | -- | -- | -- | -- | $-100.8M | $-132.1M | $-123.5M | ||
| Minority Interests | $-1.8M | $-1.6M | $-2.1M | $-2.4M | $-2.0M | $-1.0M | $-7.9M | $-6.4M | $-5.7M | $-3.1M | ||
| Net Income Discontinuous Operations | $-950.0K | $280.0K | $-137.0K | $1.5M | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $-23.4M | $-21.8M | $-26.3M | $-30.4M | $517.6M | $528.9M | $619.9M | $665.1M | $747.9M | $751.0M | ||
| Other Write Off | -- | $-500.0K | -- | -- | -- | -- | -- | -- | $3.8M | $22.2M | ||
| Otherunder Preferred Stock Dividend | -- | -- | -- | -- | -- | -- | -- | $7.5M | $-5.7M | -- | ||
| Preferred Stock Dividends | -- | -- | -- | -- | -- | -- | -- | $7.5M | $-5.7M | -- | ||
| Rent And Landing Fees | $-23.4M | $-21.8M | $-26.3M | $-30.4M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $300.4M | $367.5M | $371.3M | $443.9M | -- | -- | -- | -- | -- | -- | ||
| Write Down | -- | -- | -- | -- | -- | -- | $-31.9M | $-3.2M | -- | -- | ||
| Restruct | $-63.3M | $-55.3M | $-82.4M | $-140.1M | $-140.5M | $-166.6M | $-228.8M | $-324.7M | $-318.5M | $-233.0M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRL | $155.39 | -1.0% | 1.28M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Charles River Laboratories International Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW